TGA Approval

SURVANTA beractant (as phospholipids) 200mg/8mL suspension vial (48406)

ARTG ID

48406

ARTG Name

SURVANTA beractant (as phospholipids) 200mg/8mL suspension vial

Sponsor

AbbVie Pty Ltd

ARTG Date

March 18, 1994

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ABBVIE PTY LTD

https://medical-cdn.nocode.com/drug_tga/6767d693a9fc9390900395b81e890e2f.pdf

https://medical-cdn.nocode.com/drug_tga/36fc7772368648e0d568b87f8b66f8a3.pdf

Ingredient Name

Beractant

Empowering clinical research with data-driven insights and AI-powered tools.

SURVANTA beractant (as phospholipids) 200mg/8mL suspension vial (48406) - TGA 批准文号 | MedPath